Biochemistry of Atherosclerosis / Advances in Biochemistry in Health and Disease Bd.1 (PDF)

Name: Biochemistry of Atherosclerosis / Advances in Biochemistry in Health and Disease Bd.1
Brand: Springer-Verlag GmbH
SKU: 29550415
Price: 219.99 EUR
Availability: OnlineOnly

(Sprache: Englisch)

Schreiben Sie einen Kommentar zu "Biochemistry of Atherosclerosis / Advances in Biochemistry in Health and Disease Bd.1".

Merken

About the Series:

...

Mehr zum Inhalt Autorenporträt Inhaltsverzeichnis Video

Leider schon ausverkauft

Bestellnummer: 29550415

eBook (pdf) 219.99 €

Download bestellen

Verschenken

Lastschrift, Kreditkarte, Paypal, Rechnung
Kostenloser tolino webreader

Produktdetails

Produktbeschreibung
Inhaltsverzeichnis
Autorenporträt
eBook Hilfe
Biblio. Angaben / Produktdetails

Produktinformationen zu „Biochemistry of Atherosclerosis / Advances in Biochemistry in Health and Disease Bd.1 (PDF)“

About the Series:

Advances in Biochemistry in Heath and Disease presents state-of-the-art discussions in cutting-edge biochemical research, offering exciting developments that impact healthcare and disease research. Volumes in the series focus on cross-disciplinary biomedical research and examine various topics in biochemistry, cell biology, molecular biology, and biomedicine.

Biochemistry of Atherosclerosis

Sukhinder Kaur Cheema

Biochemistry of Atherosclerosis examines atherosclerosis in great detail, focusing on the risk of atherosclerosis, and the biochemical pathways involved. It provides a breadth of knowledge as well as new insights into a variety of topics relating to atherosclerosis from leading scientists around the world who are at the forefront of atherosclerosis research. Biochemistry of Atherosclerosis is essential reading for biomedical and clinical researchers.

Key topics:

Hyperlipidaemia and Atherosclerosis

Diabetes Induced Atherosclerosis

Hypertension Induced Atherosclerosis

Homocysteine Metabolism and Atherosclerosis

Role of the Immune System in Atherosclerosis

Role of Infectious Agents in Atherogenesis

Dietary Management of Aherosclerosis

About the Editor:

Sukhinder Kaur Cheema is currently Associate Professor of Biochemistry and a CIHR (Canadian Institutes of Health Research) New Investigator at the Memorial University of Newfoundland. An expert in nutritional biochemistry, lipid metabolism and cardiovascular disease, she is cross appointed in Faculty of Medicine at the Memorial University of Newfoundland.

Inhaltsverzeichnis zu „Biochemistry of Atherosclerosis / Advances in Biochemistry in Health and Disease Bd.1 (PDF)“

The role of HDL in the prevention of atherosclerosis.- Cholesterol breakdown and the significance in atherosclerosis.- Triacylglycerol hydrolase, VLDL assembly and development of atherosclerosis.- Regulation of Hepatic Production of Lipoproteins Containing Apolipoprotein B and the significance in atherosclerosis.- Dyslipidemia and thrombogenesis.- Mouse models of Diabetes and Atherosclerosis.- Role of the unfolded protein response in atherosclerosis: a potential unifying theory of atherogenesis.- SR-BI, reverse cholesterol transport and atherogenesis.- Hypertension and atherosclerosis.- Dietary fats, transcription factors and heart health.- Dietary fatty acid intake and stroke.- Homocysteine metabolism and atherosclerosis.- Vitamin supplements in preventing atherosclerosis.- Oxidized lipids and heart disease.- Reverse cholesterol transport and prevention of atherosclerosis.- Homocysteine, diabetes mellitus and atherosclerosis.- Treating low HDL-From bench to bedside.- Atherosclerosis is an infectious disease.

Autoren-Porträt

Dr. Sukhinder K. Cheema is Associate Professor of Biochemistry, Memorial University of Newfoundland, Canada. She has worked as a Research Scientist with the Nova-Husky Research Corporation in Alberta, Canada. She is currently researching the molecular mechanisms of cholesterol ester transfer protein regulation by dietary fats and hormones. She also researches the regulation of genes involved in cholesterol metabolism by hormone factors, the molecular basis of diabetes-accelerated atherosclerosis, and the mechanisms of lipid abnormalities caused by protease inhibitors.